Specifically, GLP-1 use was associated with an 18% lower risk of a composite TED-related diagnosis at one year and a 10% lower risk at three years. This retrospective, population-based cohort study used the TriNetX US Collaborative Network to identify patients with thyroid disease initiating a GLP-1 drug or a non-GLP-1 active control medication
Additionally, flavored variations of this product contain sucralose, an artificial sweetener
Determining Candidacy for Semaglutide Treatment Residents of Brandon considering semaglutide for weight loss should know that candidates typically possess a BMI of 30 or higher or a BMI of at least 27 with a weight-associated medical condition like hypertension, type 2 diabetes, or high cholesterol
Patient variability makes it easier to discuss shared concerns, such as how some can shed pounds rapidly and others take their time
This is a reasonable option for patients with BMI 30 to 35 without urgent comorbidities
At the same time, patient expectations have shifted